Ftse Mib
33.986,90
0,00%
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.416,56
0,40%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cognition Therapeutics Inc (CGTX) Cognition Therapeutics Inc (CGTX) Notizie

Cognition Therapeutics Inc

CGTX
1,99
0,06 (3,11%)
06 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/3/202421:11EDGAR2Form 8-K - Current report
11/3/202421:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/2/202422:44EDGAR2Form 8-K - Current report
20/2/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202421:07EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
08/1/202422:11EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
04/1/202422:21EDGAR2Form 8-K - Current report
04/1/202413:30GLOBECognition Therapeutics CEO Issues Letter to Shareholders
29/12/202322:02EDGAR2Form S-3 - Registration statement under Securities Act of..
16/11/202313:30GLOBECognition Therapeutics Releases New Episode of..
15/11/202313:30GLOBECognition Therapeutics Presents Preclinical Data Identifying..
13/11/202323:25EDGAR2Form SC 13D/A - General statement of acquisition of..
13/11/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202313:30GLOBECognition Therapeutics Completes Enrollment in Phase 2 SHINE..
02/11/202312:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202312:41EDGAR2Form 8-K - Current report
02/11/202312:30GLOBECognition Therapeutics Reports Third Quarter 2023 Financial..
27/10/202313:30GLOBECognition Therapeutics and Collaborators at Yale and ACTC..
24/10/202322:30GLOBECognition Therapeutics Presents Complete EEG Findings from..
16/10/202313:30GLOBECognition Therapeutics Presents New Data at CTAD Conference..
12/9/202313:00EDGAR2Form 8-K - Current report
07/9/202313:45GLOBECognition Therapeutics Announces New Conversations Episode..
30/8/202314:00GLOBECognition Therapeutics Announces Participation in Upcoming..
24/8/202313:00EDGAR2Form 8-K - Current report
08/8/202313:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:05EDGAR2Form 8-K - Current report
08/8/202313:00GLOBECognition Therapeutics Reports Second Quarter 2023 Financial..
02/8/202313:30GLOBECognition Therapeutics to Report Second Quarter 2023 Results..
11/7/202313:30GLOBECognition Therapeutics Announces Dosing of First Patient in..
05/7/202313:30GLOBECognition Therapeutics and the Alzheimer's Clinical Trials..
28/6/202313:00GLOBECognition Therapeutics Announces Positive Topline Results..
28/6/202301:17GLOBECognition Therapeutics to Host Call and Webcast to Discuss..
20/6/202313:30GLOBECognition Therapeutics Invited to Participate on Panel..
02/6/202313:30GLOBECognition Therapeutics Continues Investor Engagement in June..
23/5/202313:30GLOBECognition Therapeutics Latest Episode of “Conversations”..
18/5/202313:30GLOBECognition Therapeutics Publishes Clinical Evidence that..
Apertura: 1,95 Min: 1,95 Max: 2,00
Chiusura: 1,93

La tua Cronologia

NASDAQ
CGTX
Cognition Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network